There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Valneva (VALN – Research Report), Denali Therapeutics (DNLI – Research Report) and Armata Pharmaceuticals (ARMP – Research Report) with bullish sentiments.
Valneva (VALN)
H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva today and set a price target of $26.00. The company’s shares closed last Tuesday at $7.50, close to its 52-week low of $6.58.
According to TipRanks.com, White has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Currently, the analyst consensus on Valneva is a Moderate Buy with an average price target of $26.00.
See the top stocks recommended by analysts >>
Denali Therapeutics (DNLI)
In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Denali Therapeutics, with a price target of $95.00. The company’s shares closed last Tuesday at $16.85, close to its 52-week low of $14.56.
According to TipRanks.com, Fein is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Denali Therapeutics with a $44.60 average price target, a 156.8% upside from current levels. In a report issued on May 1, BTIG also maintained a Buy rating on the stock with a $35.00 price target.
Armata Pharmaceuticals (ARMP)
In a report released today, Michael Higgins from Ladenburg Thalmann & Co. reiterated a Buy rating on Armata Pharmaceuticals, with a price target of $9.00. The company’s shares closed last Tuesday at $2.86.
According to TipRanks.com, Higgins is a 4-star analyst with an average return of
Currently, the analyst consensus on Armata Pharmaceuticals is a Moderate Buy with an average price target of $8.00, a 192.0% upside from current levels. In a report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $7.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on VALN:
